After some media reports pointed out that the internal documents on India’s Covid-19 vaccine raise troubling questions about approval process, Bharat Biotech in a statement condemned the targeted narrative against COVAXIN and asserted that there was no external pressure to accelerate development of COVAXIN. The company clarified that the pressure was all internal to develop a safe, and effective vaccine for the Covid-19 pandemic.
“It is well known that they helped perpetuate misinformation and fake news throughout the pandemic. They are unable to comprehend global product development and licensure processes,” the Biotech company said in a statement.
(More details awaited…)